Home > Healthcare IT > Global Molecular Diagnostics Market Size, Share and Growth by 2030
Straits Research

Molecular Diagnostics Market

Molecular Diagnostics Market: Information by Product & Service, Technology, Application, End User and Regional Outlook — Forecast Till 2030

Table of Content Download Sample

Market Overview

The global molecular diagnostics market size was worth USD 37.23 billion in 2021 and is expected to reach USD 56.3 billion by 2030, growing at a CAGR of 4.7% over the forecast period. (2022–2030)

Molecular diagnostic is an essential part of the clinical laboratory. Increased use of molecular diagnostics in pre-clinical development and approval of drugs for therapeutics and diagnosis purposes. In addition, partnerships between pharmaceutical companies with diagnostic firms for the development of their drug test facility have made it an indispensable tool. The rising prevalence of chronic disease and the need for customized solutions have paved the way for molecular diagnostics in disease diagnosis. These are also effective in identifying underlying molecular defects in hereditary diseases. In today’s time, it is the key element for the transformation of healthcare and leading in the field of molecular biology. Some of the innovations are next-generation sequencing, microarray technologies, liquid biopsies, early cancer detection, and point-of-care assays. As per Global Genes, around 350 million people suffer from rare diseases worldwide. 8 in 10 rare diseases are caused by a mutation in genes.

Technological advancements in molecular diagnostics by key players to provide greater accuracy, portability, and cost-effectiveness are positively impacting the growth of the market. For instance, in 2015, Cepheid launched GeneXpert Omni, which is the world's most portable molecular diagnostics system.


Market Snapshot

market snapshot
Base Year
: 2021
Study Period
: 2020-2030
: 4.7 %
Fastest Growing Market
: Europe
Largest Market
: North America
Market Size
: USD 56.3 billion by 2030
Get more information on this report Download Sample Report

Segmental Analysis

The global molecular diagnostics market industry is segmented by product & service, technology, application and end user.

By product & service, the market is segmented into reagents and kits, instruments and software & services. The reagents and kits segment is expected to grow at the fastest CAGR. The growth can be attributed to the availability of a variety of reagents & kits and the growing usage of reagents and kits in diverse therapeutic areas such as infectious diseases and oncology.

Based on technology, the global molecular diagnostics market is segmented into PCR, INAAT, DNA sequencing & NGS, in situ hybridization, DNA microarrays, and other technologies. The PCR segment is expected to hold the largest share due to the increasing usage of PCR in genomics and the development of automated PCR instruments.

By technology, the molecular diagnostics market is segmented globally into enzyme-linked immunosorbent assays (ELISA), rapid tests, western blotting, enzyme-linked immunospot (ELISPOT), immuno-PCR, and other technologies. The ELISA segment is expected to generate the highest revenue in the forecast period as it is the most preferred immunoassay test for the diagnosis of cancer, infectious diseases, and therapeutic drug level monitoring.

The end-user segment is classified into hospitals and academic laboratories, reference laboratories, and other end users. The hospitals and academic laboratories segment as the majority of diagnostic tests are performed in hospitals.

Regional Analysis

Geographically, the global molecular diagnostics market industry is segmented into four regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa (LAMEA).

North America is likely to dominate the molecular diagnostics market due to the high prevalence of infectious diseases, highly developed healthcare systems,s and increasing applications of molecular diagnostics in genetic disorders and cancer screening. As per the American Cancer Society, around 609,640 Americans are expected to die of cancer in 2018. Early screening can help in the prevention and detection of these life-threatening diseases.

Europe is likely to emerge as the second-largest molecular diagnostics market globally. This can be attributed to the increasing cancer disease burden and strong government policies to reduce the number of chronic diseases. Cancer is the second leading cause of mortality in the EU after cardiovascular diseases, with around 1.4 million deaths estimated in 2018.

Asia pacific immunoassay market is expected to witness significant growth on account of increasing development and production of vaccines & drugs and growing medical treatment for infectious and chronic diseases. In 2017, there were 11,923 combined new cases of leukemia, lymphoma, and myeloma in Australia.

LAMEA is expected to witness steady growth as government health budgets in Latin America are small compared to developed economies. As per the American Cancer Society, around 1.1 million new cancer cases and 600,000 cancer deaths are estimated to occur annually in Latin America.

Molecular Diagnostics Market Regional Analysis
Regional Growth Insights Download Free Sample

Top Key Players of Molecular Diagnostics Market

Some of the key players in the global molecular diagnostics market are 

  1. Abbott Laboratories
  2. Agilent Technologies
  3. Siemens AG
  4. Biomérieux Sa
  5. Becton
  6. Dickinson and Company
  7. Thermo Fisher Scientific
  8. Danaher Corporation
  9. Illumina
  10. Roche Diagnostics
  11. Hologic
  12. Qiagen

Report Scope

Report Metric Details
CAGR 4.7%
Forecast Period 2023-2031
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends
Segments Covered
  1. By Product & Service
    1. Reagents & Kits
    2. Instruments
    3. Software & Services
  2. By Technology
    1. Polymerase Chain Reaction (PCR)
    2. Isothermal Nucleic Acid Amplification Technology (INAAT)
    3. DNA Sequencing & Next-Generation Sequencing (NGS)
    4. In Situ Hybridization
    5. DNA Microarray
    6. Other Technologies
  3. By Application
    1. Infectious Diseases
    2. Hepatitis
    3. HIV
    4. CT/NG
    5. HAIS
    6. HPV
    7. Tuberculosis
    8. Influenza
    9. Other Infectious Diseases
    10. Oncology
    11. Breast Cancer
    12. Colorectal Cancer
    13. Lung Cancer
    14. Prostate Cancer
    15. Other Cancers
    16. Genetic Tests
    17. Other Applications
  4. By End-User
    1. Hospital & Academic Laboratories
    2. Reference Laboratories
    3. Other End Users
Geographies Covered
  • North America
  • Europe
  • APAC
  • Middle East and Africa

Molecular Diagnostics Market Segmentation

By Product & Service

  • Reagents & Kits
  • Instruments
  • Software & Services

By Technology

  • Polymerase Chain Reaction (PCR)
  • Isothermal Nucleic Acid Amplification Technology (INAAT)
  • DNA Sequencing & Next-Generation Sequencing (NGS)
  • In Situ Hybridization
  • DNA Microarray
  • Other Technologies

By Application

  • Infectious Diseases
  • Hepatitis
  • HIV
  • CT/NG
  • HAIS
  • HPV
  • Tuberculosis
  • Influenza
  • Other Infectious Diseases
  • Oncology
  • Breast Cancer
  • Colorectal Cancer
  • Lung Cancer
  • Prostate Cancer
  • Other Cancers
  • Genetic Tests
  • Other Applications

By End-User

  • Hospital & Academic Laboratories
  • Reference Laboratories
  • Other End Users

Regions Covered

  • North America

    • U.S.
    • Canada
    • Mexico
  • Europe

    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific

    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Rest of Asia-Pacific

    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
Price Starts From
USD 995

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report
Want to learn more about recent trends and data ?
They Already Trust Us :
Nippon Becton Dickinson
Argon Medical Devices
Johnson & Johnson
Need Assistance?
+1 646 480 7505 (U.S.)
+44 208 068 9665 (U.K.)

Report Benefits

  • Develop business strategies by understanding the trends shaping and driving the Market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analysing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track sales in the global and country-specific Market.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
Report Snapshot
Looking For Custom Report ?
Check Our License Options :

As featured on :

Trusted by Fortune 500
Over 30000+ subscribers